100 related articles for article (PubMed ID: 16397277)
1. The magnetic resonance imaging contrast agent mangafodipir exerts antitumor activity via a previously described superoxide dismutase mimetic activity.
Karlsson JO; Brurok H; Towart R; Jynge P
Cancer Res; 2006 Jan; 66(1):598; author reply 598. PubMed ID: 16397277
[No Abstract] [Full Text] [Related]
2. Improvement of the therapeutic index of anticancer drugs by the superoxide dismutase mimic mangafodipir.
Alexandre J; Nicco C; Chéreau C; Laurent A; Weill B; Goldwasser F; Batteux F
J Natl Cancer Inst; 2006 Feb; 98(4):236-44. PubMed ID: 16478742
[TBL] [Abstract][Full Text] [Related]
3. Protective effects of mangafodipir against chemotherapy-induced ovarian damage in mice.
Qin Y; Iwase A; Murase T; Bayasula ; Ishida C; Kato N; Nakamura T; Osuka S; Takikawa S; Goto M; Kotani T; Kikkawa F
Reprod Biol Endocrinol; 2018 Oct; 16(1):106. PubMed ID: 30368246
[TBL] [Abstract][Full Text] [Related]
4. Contrast-enhanced magnetic resonance cholangiography using mangafodipir compared with standard T2W MRC sequences: a pictorial essay.
Sheppard D; Allan L; Martin P; McLeay T; Milne W; Houston JG
J Magn Reson Imaging; 2004 Aug; 20(2):256-63. PubMed ID: 15269951
[TBL] [Abstract][Full Text] [Related]
5. Antioxidant activity of mangafodipir is not a new finding.
Karlsson JO
J Hepatol; 2004 May; 40(5):872-3; author reply 873. PubMed ID: 15094242
[No Abstract] [Full Text] [Related]
6. Calmangafodipir [Ca4Mn(DPDP)5], mangafodipir (MnDPDP) and MnPLED with special reference to their SOD mimetic and therapeutic properties.
Karlsson JO; Ignarro LJ; Lundström I; Jynge P; Almén T
Drug Discov Today; 2015 Apr; 20(4):411-21. PubMed ID: 25463039
[TBL] [Abstract][Full Text] [Related]
7. [MnDPDP--contrast medium with protective effect in acute myocardial infarction].
Hemmingsson A
Lakartidningen; 2002 Oct; 99(40):3955-6. PubMed ID: 12422752
[No Abstract] [Full Text] [Related]
8. Redox modulation of chemotherapy-induced tumor cell killing and normal tissue toxicity.
Doroshow JH
J Natl Cancer Inst; 2006 Feb; 98(4):223-5. PubMed ID: 16478735
[No Abstract] [Full Text] [Related]
9. Metal ion chelating peptides with superoxide dismutase activity.
Fisher AE; Naughton DP
Biomed Pharmacother; 2005 May; 59(4):158-62. PubMed ID: 15862709
[TBL] [Abstract][Full Text] [Related]
10. Re: diagnostic accuracy of portal-phase CT and MRI with mangafodipir trisodium in detecting liver metastases from colorectal carcinoma.
Bryant M; Higginson A
Clin Radiol; 2007 Aug; 62(8):817; author reply 817. PubMed ID: 17604776
[No Abstract] [Full Text] [Related]
11. Uptake of MnCl2 and mangafodipir trisodium in the myocardium: a magnetic resonance imaging study in pigs.
Eriksson R; Johansson L; Bjerner T; Briley Saebo K; Ahlström H
J Magn Reson Imaging; 2004 May; 19(5):564-9. PubMed ID: 15112305
[TBL] [Abstract][Full Text] [Related]
12. Axon tracing in the adult rat optic nerve and tract after intravitreal injection of MnDPDP using a semiautomatic segmentation technique.
Olsen Ø; Thuen M; Berry M; Kovalev V; Petrou M; Goa PE; Sandvig A; Haraldseth O; Brekken C
J Magn Reson Imaging; 2008 Jan; 27(1):34-42. PubMed ID: 18157895
[TBL] [Abstract][Full Text] [Related]
13. Prooxidant activity of the superoxide dismutase (SOD)-mimetic EUK-8 in proliferating and growth-arrested Escherichia coli cells.
Matthijssens F; Back P; Braeckman BP; Vanfleteren JR
Free Radic Biol Med; 2008 Sep; 45(5):708-15. PubMed ID: 18573332
[TBL] [Abstract][Full Text] [Related]
14. Characterization of focal liver lesions: use of mangafodipir trisodium (MnDPDP)-enhanced MR images.
Karabacakoğlu A; Adigüzel Y; Karaköse S; Kayaçetin E; Haykir R
Turk J Gastroenterol; 2006 Sep; 17(3):164-71. PubMed ID: 16941248
[TBL] [Abstract][Full Text] [Related]
15. Relaxation enhancing properties of MnDPDP in human myocardium.
Skjold A; Vangberg TR; Kristoffersen A; Haraldseth O; Jynge P; Larsson HB
J Magn Reson Imaging; 2004 Dec; 20(6):948-52. PubMed ID: 15558550
[TBL] [Abstract][Full Text] [Related]
16. Prevention of 7β-hydroxycholesterol-induced cell death by mangafodipir is mediated through lysosomal and mitochondrial pathways.
Laskar A; Miah S; Andersson RG; Li W
Eur J Pharmacol; 2010 Aug; 640(1-3):124-8. PubMed ID: 20452343
[TBL] [Abstract][Full Text] [Related]
17. Manganese-Enhanced MRI of the Brain in Healthy Volunteers.
Sudarshana DM; Nair G; Dwyer JT; Dewey B; Steele SU; Suto DJ; Wu T; Berkowitz BA; Koretsky AP; Cortese ICM; Reich DS
AJNR Am J Neuroradiol; 2019 Aug; 40(8):1309-1316. PubMed ID: 31371354
[TBL] [Abstract][Full Text] [Related]
18. Manganese dipyridoxyl diphosphate: MRI contrast agent with antioxidative and cardioprotective properties?
Brurok H; Ardenkjaer-Larsen JH; Hansson G; Skarra S; Berg K; Karlsson JO; Laursen I; Jynge P
Biochem Biophys Res Commun; 1999 Jan; 254(3):768-72. PubMed ID: 9920816
[TBL] [Abstract][Full Text] [Related]
19. Mangafodipir prevents liver injury induced by acetaminophen in the mouse.
Bedda S; Laurent A; Conti F; Chéreau C; Tran A; Tran-Van Nhieu J; Jaffray P; Soubrane O; Goulvestre C; Calmus Y; Weill B; Batteux F
J Hepatol; 2003 Nov; 39(5):765-72. PubMed ID: 14568259
[TBL] [Abstract][Full Text] [Related]
20. [MR and biliary tract].
Chabanova E; Møller JM; Løgager V; Thomsen HS
Ugeskr Laeger; 2005 Aug; 167(35):3321-2; author reply 3322-3. PubMed ID: 16138986
[No Abstract] [Full Text] [Related]
[Next] [New Search]
